Is OPRX stock a Buy, Sell, or Hold?

Based on our analysis, OPRX is currently a HOLD with low confidence. 📊 HOLD: OPRX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of OPRX stock?

Our analysis estimates the fair value range for OPRX to be between $11.41 and $13.18. The current price is $10.92.

What is the analyst price target for OPRX?

The average Wall Street analyst price target for OPRX is $24.33. This implies a potential upside of 122.8% from current levels.

OPRX Stock Analysis: Buy, Sell, or Hold?

OPRX - OptimizeRx Corporation Common Stock

SERVICES-BUSINESS SERVICES, NEC

$10.92

0.16 (1.49%) ▲

5d: -6.19%

30d: -10.93%

90d: -44.31%

HOLD

LOW Confidence

Protect Your OPRX Gains

Last Updated: February 2, 2026

Earnings: Mar 11, 2026

Smart Money Accumulation

OPRX is down 5.8% this week, but smart money is accumulating calls. Top strike: $10 2026-03-20 with 12 OI. Call ratio: 100% View Scanner →

Strength: 7.9/10

Get Alerted When OPRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: OPRX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 15.7%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$20.63

Based on 9.9% avg growth

INTRINSIC VALUE TODAY

$12.81

14.8% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: OPRX is currently trading at $10.92, which is considered oversold relative to its 30-day fair value range of $11.41 to $13.18. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.7) compared to its historical average (15.0). Remarkably, the market is currently pricing in an annual earnings decline of 5.5% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, OPRX is in a strong downtrend. Immediate support is located at $10.34, while resistance sits at $12.34.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $24.33 (+122.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Fair Price Range $11.41 - $13.18

Company Quality Score 46/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 83.5%

Protect Your Profits

Holding OPRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BULLISH: Options cheap (IV 0th percentile)
NEUTRAL: Mixed technical signals (40/100)
BULLISH: High volume confirmation
BULLISH: Trading 122.8% below Wall St target ($24.33)
CAUTION: Recommendation downgraded due to -6.2% 5-day decline

Fair Price Analysis

30-Day Fair Range $11.41 - $13.18

Current vs Fair Value OVERSOLD

Expected Move (7 Days) ±$1.38 (12.7%)

Support & Resistance Levels

Support Level $10.34

Resistance Level $12.34

Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 12.66

Wall Street Target $24.33 (+122.8%)

Revenue Growth (YoY) 22.3%

Earnings Growth (YoY) -66.8%

Valuation Discount vs History -5.5% cheaper

PE vs Historical 12.7 vs 15.0 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -5.5% (market-implied from PE analysis)

1-Year Target $10.32 (-6%)

2-Year Target $9.75 (-11%)

3-Year Target $9.22 (-16%)

3-Yr Target (if PE normalizes) (PE: 13→15) $10.92 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 22.3, Growth: 15.7%) $29.82 (+173%)

Base: (SPY PE: 12.7, Growth: 15.7%) $16.92 (+55%)

Bear: (PE: 10.8, Growth: 15.7%) $14.38 (+32%)

📈 Valuation based on Current Earnings

Forward PE: 12.02 | Forward EPS (Implied): $0.91

Bull Case $13.19 (+21%)

Analyst growth 15.0%, PE expands to 12.6

Base Case $10.92 (0%)

Market implied 0.0%, PE stable at 12.0

Bear Case $8.35 (-24%)

Severe decline -15.0%, PE contracts to 10.8

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 12.7 to 15.0

Stabilization Target: $12.94 (+18.5%)

PE Expansion Potential: +18.5%

Last updated: February 03, 2026 4:13 AM ET
Data refreshes hourly during market hours. Next update: 5:13 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is OPRX showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Stephen L Silvestro SELL 1620 shares 2025-10-03

Patrick D Spangler SELL 11120 shares 2025-08-28

View Insider Activity Scanner

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
VEEV Veeva Systems Inc Class A	BUY 32 analysts	$310	52 HOLD
PRVA Privia Health Group Inc	STRONG BUY 21 analysts	$31	55 HOLD
GEHC GE HealthCare Technologi…	STRONG BUY 21 analysts	$90	64 BUY
HQY HealthEquity Inc	STRONG BUY 14 analysts	$119	64 BUY
PHR Phreesia Inc	STRONG BUY 15 analysts	$29	49 HOLD

VEEV Veeva Systems Inc…

52 HOLD

PRVA Privia Health Gro…

55 HOLD

GEHC GE HealthCare Tec…

Advanced OPRX Option Strategies

Professional options setups generated by AI based on today's OPRX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for OPRX

OPRX Technical Chart OPRX Price Prediction OPRX Earnings Date OPRX Investment Advisor OPRX Fair Price Analyzer OPRX Options Advisor OPRX Options Chain OPRX Options Analysis OPRX Competitors

Compare OPRX with Other Stocks

Create New Comparison

Tradestie